Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erosive Disease in Early Rheumatoid Arthritis”

4 trials

Showing 4 of 4 results

Large-scale testing (Phase 3)Study completedNCT00122382
What this trial is testing

Remission and Joint Damage Progression in Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,052
Testing effectiveness (Phase 2)Study completedNCT00006292
What this trial is testing

Infliximab for the Treatment of Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 60
Large-scale testing (Phase 3)Study completedNCT00989235
What this trial is testing

Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 108
Not applicableUnknownNCT02464384
What this trial is testing

Prediction of Erosive Disease in Early Rheumatoid Arthritis (RA) by Ultrasound and Cartilage Biodegradation Markers

Who this might be right for
Erosive Disease in Early Rheumatoid Arthritis
University of Zurich 24

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation